BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21466599)

  • 1. Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality.
    Øie E; Ueland T; Dahl CP; Bohov P; Berge C; Yndestad A; Gullestad L; Aukrust P; Berge RK
    J Intern Med; 2011 Sep; 270(3):263-72. PubMed ID: 21466599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart Failure.
    Fosshaug LE; Dahl CP; Risnes I; Bohov P; Berge RK; Nymo S; Geiran O; Yndestad A; Gullestad L; Aukrust P; Vinge LE; Øie E
    J Card Fail; 2015 Nov; 21(11):916-23. PubMed ID: 26231517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure.
    Zhao YT; Shao L; Teng LL; Hu B; Luo Y; Yu X; Zhang DF; Zhang H
    J Int Med Res; 2009; 37(6):1831-41. PubMed ID: 20146881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of circulating adipokine levels and expressions of adipokines in the myocardium of patients with chronic heart failure.
    Yin WH; Wei J; Huang WP; Chen JW; Young MS; Lin SJ
    Circ J; 2012; 76(9):2139-47. PubMed ID: 22785032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
    de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
    Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.
    Gravning J; Askevold ET; Nymo SH; Ueland T; Wikstrand J; McMurray JJ; Aukrust P; Gullestad L; Kjekshus J;
    Circ Heart Fail; 2014 Jan; 7(1):96-103. PubMed ID: 24284025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IVC diameter in patients with chronic heart failure: relationships and prognostic significance.
    Pellicori P; Carubelli V; Zhang J; Castiello T; Sherwi N; Clark AL; Cleland JG
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):16-28. PubMed ID: 23328557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Defensins and outcome in patients with chronic heart failure.
    Christensen HM; Frystyk J; Faber J; Schou M; Flyvbjerg A; Hildebrandt P; Raymond I; Klausen TW; Kistorp C
    Eur J Heart Fail; 2012 Apr; 14(4):387-94. PubMed ID: 22357441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure.
    Hsu CP; Lin SJ; Chung MY; Lu TM
    Atherosclerosis; 2012 Dec; 225(2):504-10. PubMed ID: 23092827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of serum sialic acid and high-sensitivity C-reactive protein: markers of systemic inflammation in patients with chronic heart failure.
    Rajendiran KS; Ananthanarayanan RH; Satheesh S; Rajappa M
    Br J Biomed Sci; 2014; 71(1):29-32. PubMed ID: 24693572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of N-terminal pro-B-type natriuretic peptide increase with exercise for predicting cardiovascular mortality in patients with heart failure.
    Koç M; Bozkurt A; Acartürk E; Sahin DY; Unal I
    Am J Cardiol; 2008 Apr; 101(8):1157-62. PubMed ID: 18394451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure.
    Asselin C; Ducharme A; Ntimbane T; Ruiz M; Fortier A; Guertin MC; Lavoie J; Diaz A; Levy E; Tardif JC; Des Rosiers C
    Redox Biol; 2014; 2():148-55. PubMed ID: 24494189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide.
    Jungbauer CG; Riedlinger J; Buchner S; Birner C; Resch M; Lubnow M; Debl K; Buesing M; Huedig H; Riegger G; Luchner A
    Clin Chem Lab Med; 2011 Nov; 49(11):1899-906. PubMed ID: 21892905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
    Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
    Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum free thiols in chronic heart failure.
    Koning AM; Meijers WC; Pasch A; Leuvenink HGD; Frenay AS; Dekker MM; Feelisch M; de Boer RA; van Goor H
    Pharmacol Res; 2016 Sep; 111():452-458. PubMed ID: 27378569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.